Gemtesa 75 MG tablet 90S
Ended Awarded
- Contract number
- SPE2DR26F0KW8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,851
Award facts
- Contract value 100% obligated
- $11,850.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Gemtesa 75 mg tablets (90-count units) under a firm fixed-price contract valued at $11,850.60. This non-set-aside award is classified as a delivery order, reflecting a specific purchase drawn from a larger contract vehicle. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of November 19, 2025, indicating a expedited fulfillment timeline typical of medical supply procurement for federal healthcare systems.
This delivery order is executed under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply agreement extending through December 2026. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The broader IDC enables the company to supply a wide range of pharmaceutical products and medical commodities to support military healthcare programs worldwide, with customers including the Defense Health Agency and U.S. Coast Guard. This specific order for Gemtesa—a medication indicated for overactive bladder treatment—reflects the company's role in fulfilling specialized pharmaceutical needs within the federal defense healthcare supply chain.
Quick answers
Who was awarded contract SPE2DR26F0KW8?
SPE2DR26F0KW8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 18, 2025.
How much is contract SPE2DR26F0KW8 worth?
The government has obligated $11,851 on SPE2DR26F0KW8.
Is contract SPE2DR26F0KW8 an order under another contract?
Yes. SPE2DR26F0KW8 is a delivery order under SPE2DR25D3007, an indefinite delivery contract.
Was contract SPE2DR26F0KW8 competed?
The extent of competition for SPE2DR26F0KW8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award